Literature DB >> 10095984

Regulation of cholesterol metabolism by dietary plant sterols.

T A Miettinen1, H Gylling.   

Abstract

Renewal has occurred in the use of plant sterols for the treatment of hypercholesterolemias. A novel development was to convert plant sterols to corresponding stanols and esterify them to fat soluble form. In contrast to the crystalline plant sterols or stanols, plant stanol esters can be easily consumed during normal food intake in soluble form in different fat-containing food constituents when they have a potent cholesterol-lowering effect, shown in normo- and hypercholesterolemic men and women without or with coronary heart disease, children and diabetes. Cholesterol lowering is approximately 10% for total and 15% for LDL cholesterol, with the respective values for stanol ester margarine (2-3 g/day stanols) being 15% and 20%. Stanol esters reduce cholesterol absorption efficiency by up to 65%, increase cholesterol elimination in feces as cholesterol itself, usually not as bile acids, and stimulate cholesterol synthesis. Serum beta-carotene level is lowered, but no fat malabsorption or lowering of serum fat soluble vitamins have been observed. In contrast to plant sterols, stanols and their esters are minimally absorbed and they reduce serum plant sterol concentrations, also preventing statin-induced increase of plant sterols. Stanol ester margarine has been included in dietary treatment of hypercholesterolemia followed by the addition of drug treatment in resistant cases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10095984     DOI: 10.1097/00041433-199902000-00003

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  11 in total

Review 1.  Monogenic hypercholesterolemia: new insights in pathogenesis and treatment.

Authors:  Daniel J Rader; Jonathan Cohen; Helen H Hobbs
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 2.  The optimal dietary strategy to manage risk associated with various dyslipidemias.

Authors:  N J Stone
Journal:  Curr Cardiol Rep       Date:  2001-09       Impact factor: 2.931

3.  Inhibition of cholesterol biosynthesis by Delta22-unsaturated phytosterols via competitive inhibition of sterol Delta24-reductase in mammalian cells.

Authors:  Carlos Fernández; Yajaira Suárez; Antonio J Ferruelo; Diego Gómez-Coronado; Miguel A Lasunción
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

4.  Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects.

Authors:  Manny Noakes; Peter M Clifton; Anne M E Doornbos; Elke A Trautwein
Journal:  Eur J Nutr       Date:  2004-08-17       Impact factor: 5.614

Review 5.  Phytosterols in the prevention of human pathologies.

Authors:  H Tapiero; D M Townsend; K D Tew
Journal:  Biomed Pharmacother       Date:  2003-10       Impact factor: 6.529

6.  Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (HepG2).

Authors:  Ricky Y K Man; Edward G Lynn; Filly Cheung; Patricia S Y Tsang; Karmin O
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

Review 7.  Role of naturally-occurring plant sterols on intestinal cholesterol absorption and plasmatic levels.

Authors:  T Sanclemente; I Marques-Lopes; J Puzo; A L García-Otín
Journal:  J Physiol Biochem       Date:  2009-03       Impact factor: 4.158

Review 8.  The food matrix and sterol characteristics affect the plasma cholesterol lowering of phytosterol/phytostanol.

Authors:  Laura Kells Cusack; Maria Luz Fernandez; Jeff S Volek
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

9.  A review of clinical trials in dietary interventions to decrease the incidence of coronary artery disease.

Authors:  Helena Gylling; Tatu A Miettinen
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

10.  Hypolipidemic and antioxidant activity of enoki mushrooms (Flammulina velutipes).

Authors:  Ming-Yei Yeh; Wen-Ching Ko; Li-Yun Lin
Journal:  Biomed Res Int       Date:  2014-08-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.